CHICAGO, Jan. 19 /PRNewswire/ -- Lincoln International, a leading global mid-market investment bank, announced today that it has launched a new practice focused exclusively on serving the healthcare industry. To lead this practice, the firm has appointed one of the premier healthcare investment banking teams in the United States. These seasoned healthcare bankers will enable Lincoln International to offer a dedicated team that provides informed, creative and value-added healthcare M&A advisory services to clients around the world.
Shahab Fatheazam, a veteran investment banker with more than 20 years of experience representing healthcare companies in the United States, Europe and Asia, will serve as managing director and head of Lincoln International's healthcare group. As managing director, Fatheazam will formulate and execute upon the strategic direction of the group, identify prospective deals and manage key client relationships.
Joining Fatheazam are Tony Crisman and Ross Gordon, who will serve as vice presidents. Fatheazam, Crisman and Gordon were formerly with GCA Savvian Advisors and bring nearly 10 years of experience working together and more than 40 years combined healthcare expertise. The team will add substantial knowledge and global experience in healthcare M&A to Lincoln International's already strong international, multi-industry footprint.
"Lincoln International strives to provide excellent advice and services to clients across a broad spectrum of industries in each of the world's key economies," said Jim Lawson, chairman of Lincoln International. "The addition of a dedicated, U.S.-based healthcare team with extensive industry expertise, contacts, perspective and cross-border experience is very timely. With the new healthcare paradigm currently being finalized by the U.S. Congress, we anticipate significant increases in healthcare M&A, especially in the United States. Moreover, many of our existing clients in industries such as business services and chemicals currently touch the healthcare space, and this will enable us to strategically support their healthcare M&A needs."
Lincoln International's strategic focus on the healthcare industry demonstrates its commitment to serving clients more broadly, as well as its ability to respond to and leverage changing market dynamics. Current industry trends, including consolidation in the pharmaceutical and life science industries, medical technology innovations, changes to the diagnostic and research tools industries and the globalization of the services sectors, have made healthcare an increasingly viable area for M&A activity. Lincoln International's healthcare group will place a special focus on serving the diagnostic, medical technology, pharmaceutical outsourced services, research instrument, pharmaceutical, biotechnology, managed care and health and wellness subsectors.
"In Shahab, Ross and Tony, we have found a group that provides great service and outcomes to healthcare-related clients and fits with our international and integrated culture," said Rob Barr, president of Lincoln International. "With their wealth of industry contacts and insights, we're certain they'll be a strong asset to our firm and the clients we serve."
Fatheazam brings a strong track record of establishing, growing and leading successful healthcare M&A practices. Prior to joining Lincoln International, Fatheazam led the healthcare practice of GCA Savvian Advisors where he focused on a number of industry subsectors, including medical technology, diagnostics and outsourced services, among several others. Before that, Fatheazam was a senior partner at Vector Securities International, a leading healthcare investment bank, prior to its acquisition by Prudential Securities. There, he led the firm's expansion into healthcare services and the diagnostic and research tools sectors. He also served as co-head of Paine Webber's life science funding subsidiary, in addition to working at the international investment banking department of Kidder, Peabody & Co.
Crisman and Gordon bring extensive healthcare experience in M&A, capital markets, corporate strategy and private equity to their new roles at Lincoln International. In addition to serving as vice president of GCA Savvian Advisors, Crisman has held various positions at investment banking firms such as Dain Rauscher Wessels (now part of RBC Capital Markets) and Vector Securities International in the healthcare sector. Gordon previously served as vice president of GCA Savvian Advisors and, before that, worked as director of strategy for American Express. Gordon also held positions at Vector Securities International, as well as in the private equity units of American Express and General Electric earlier in his career.
"Lincoln International's global footprint and its deep commitment to enhancing the firm's healthcare industry capabilities forms the basis on which to expand and build a truly international healthcare business committed to exceptional client service," said Fatheazam. "The needs of the industry are evolving, and we look forward to providing our expertise to the companies in the sectors we serve."
About Lincoln International
Lincoln International specializes in merger and acquisition advisory services, private capital raising, U.K. pensions advisory services and providing restructuring advice, fairness opinions and valuations for leading organizations involved in mid-market transactions. With offices in Chicago, Frankfurt, London, Los Angeles, Madrid, New York, Paris, Tokyo and Vienna, and strategic partnerships with China Everbright in China and ICICI Securities, Inc. in India, Lincoln International has strong local knowledge and contacts in the key global economies. The organization provides clients with senior-level attention, in-depth industry expertise, and integrated resources. By being focused and independent, Lincoln International serves its clients without conflicts of interest. More information about Lincoln International can be obtained at www.lincolninternational.com.
SOURCE Lincoln International